Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
NCT01950611Phase 2Unknown
- Sponsor
- Christian Medical College, Vellore
- Start
- May 2013
- Primary completion
- May 2018
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in acute promyelocytic leukemia (APL), sponsored by Christian Medical College, Vellore. Status: unknown.
02
Drugs
bortezomib
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT01950611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950611.